Market revenue in 2023 | USD 125.5 million |
Market revenue in 2030 | USD 164.5 million |
Growth rate | 3.9% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 23.27% in 2024. Horizon Databook has segmented the North America dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global market in 2022, which can be attributed to rise in the demand for diagnostics due to increase in the incidence of chronic diseases and easy availability of technologically advanced diagnostic techniques. In addition, increasing incidence of infectious diseases in the region, such as COVID-19, tuberculosis, HIV, and influenza, is expected to boost the demand for detection & treatment.
Furthermore, presence of well-established healthcare infrastructure and availability of government funding for research are among the factors anticipated to augment market growth in this region. In July 2020, NIH invested USD 248.7 million in development of new technologies to address challenges associated with testing for COVID-19.
NIH’s Rapid Acceleration of Diagnostics (RADx) initiative awarded contracts to seven biomedical diagnostic companies in order to support development of COVID-19 POC and lab-based tests and increase their availability.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dried blood spot collection cards market , including forecasts for subscribers. This continent databook contains high-level insights into North America dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account